AzTrials
AzTrials

Voice DisordersEarly Phase 1NCT01435837

Interaction of Caffeine and Hydration on Voice

A Early Phase 1 study testing C2 (200mg of caffeine; 1/2 L of water), C3(200mg of caffeine; 1 L of water) and C1 (200mg of caffeine, no water) in people with Voice Disorders, run by Southern Illinois University Carbondale at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study, Effects of Interaction of Caffeine and Hydration on Voice Performance, is to gather information about the effects of caffeine and hydration upon voice performance. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Voice Disorders
What is being tested?
C2 (200mg of caffeine; 1/2 L of water), C3(200mg of caffeine; 1 L of water) and C1 (200mg of caffeine, no water)
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
80 participants
Where
1 siteUnited States
Study dates
Oct 2010to May 2013
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy individuals, ranging from 18 to 35 years of age.

Who cannot join

  • History of voice disorders, history of coronary disease, history of high blood pressure.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Southern Illinois University Carbondale

    Carbondale, Illinois, 62901

Other trials in United States

About this study

Official title: Effects of the Interaction of Caffeine and Hydration on Voice Performance

The purpose of the study, Effects of Interaction of Caffeine and Hydration on Voice Performance, is to gather information about the effects of caffeine and hydration upon voice performance. The research question involves whether systemic hydration may reduce degradation on voice performance caused by caffeine ingestion. It is hypothesized that the hydration conditions will result in a less degraded vocal performance as compared with the nonhydration condition.The investigation involves abstention from any caffeine ingestion for 24 hours - from 8pm the day before testing to 8am the morning of testing. In addition, preparation for participation involves abstaining from ingesting any foods and liquids for 12 hours - from 8pm to 8am of the following morning. Each test will take about 10 minutes.

Read the detailed description

The objective of this investigation is to explore the interaction of water and caffeine on voice performance through (a) acoustic measures of voice, and (b) aerodynamic measurements (minimum lung pressure required to initiate phonation. The acoustic and aerodynamic measurements were selected for this study in an effort to demonstrate the effects of four levels of hydration and caffeine status on voice quality: 1) caffeine and water1 (i.e.., Experimental Group 1 - ingestion of 200 mg of caffeine in conjunction with 500 ml of water), 2) caffeine and water2 (i.e., Experimental Group 2 - ingestion of 200 mg of caffeine in conjunction with 1.0 liter of water), 3)caffeine only (i.e., Experimental Group 3: ingestion of 200 mg of caffeine and no water), and 4) control (i.e. no ingestion of caffeine or water). The research question involves whether systemic hydration may reduce degradation on voice performance caused by caffeine ingestion. It is hypothesized that the hydration conditions will result in a less degraded vocal performance as compared with the nonhydration condition. Additionally, it is hypothesized that ingestion of 1.0 liter of water will have a greater effect on voice performance than ingestion of 500 ml of water. An additional objective of this study is to increase scientific knowledge of voice functioning by providing further data about the effect of the interaction of water and caffeine on voice performance. The results of this project may be a valuable addition to the scientific literature in vocology, and may also contribute to prevention plans for minimizing vocal disturbances. Therefore, vocational programs may include vocal prevention directions based on this study. In addition, knowledge about prevention of voice disorders may be included in the academic curriculum of students enrolled in training programs for professions involving substantial voice use.

Conditions
Voice Disorders
Being tested
C2 (200mg of caffeine; 1/2 L of water), C3(200mg of caffeine; 1 L of water), C1 (200mg of caffeine, no water), Placebo (no caffeine, no water).
Keywords
Voice, aerodynamics, acoustics
Medical subject headings
Voice Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • C2 (200mg of caffeine; 1/2 L of water)Drug

    Also called Caffeine and water 2.

    200mg of caffeine (tablet); 1/2 of water

  • C3(200mg of caffeine; 1 L of water)Drug

    Also called Caffeine and water 3.

    Ingestion of 200 mg of caffeine and 1 Liter of water after between pretest and posttest.

  • C1 (200mg of caffeine, no water)Drug

    Also called Caffeine

    Ingestion of 200mg of caffeine (tablet); no water ingestion.

  • Placebo (no caffeine, no water).Drug

    Also called Control.

    No ingestion of caffeine; no ingestion of water between pretest and posttest.

Study groups in NCT01435837
Study groupRoleWhat they receive
Caffeine and hydration.Experimental200 mg of caffeine (over the counter caffeine tablet) 1 liter of water
Receives: Drug: C2 (200mg of caffeine; 1/2 L of water); Drug: C3(200mg of caffeine; 1 L of water); Drug: C1 (200mg of caffeine, no water); Drug: Placebo (no caffeine, no water).
No caffeine, no hydration.Placebo comparatorNot described
Receives: Drug: C2 (200mg of caffeine; 1/2 L of water); Drug: C3(200mg of caffeine; 1 L of water); Drug: C1 (200mg of caffeine, no water); Drug: Placebo (no caffeine, no water).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effect of caffeine and hydration on acoustic measures of voice.

    The acoustic measurement of voice include the parameters of relative average perturbation (RAP), shimmer, and sound pressure level (SPL).

    Measured: 1 year

Secondary outcomes (1)
  1. Effect of caffeine and hydration on aerodynamic measures of voice. Effect of caffeine and hydration on aerodynamic measures of voice.

    The aerodynamic measurement of voice includes the parameter of airflow. Airflow measurements refer to the amount of air passing through the region of the vocal folds decibels.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2011 (estimated)
  2. Study startOct 2010
  3. Primary completionMay 2013
  4. Study completionMay 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01435837
Sponsor's protocol ID
09433
Status last verified
Jun 2013
First submitted
24 Sep 2010
Last updated
11 Jun 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing C2 (200mg of caffeine; 1/2 L of water), C3(200mg of caffeine; 1 L of water) and C1 (200mg of caffeine, no water) in people with Voice Disorders, run by Southern Illinois University Carbondale at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effect of caffeine and hydration on acoustic measures of voice. (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in